Breeze Meds vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Shed beats Breeze Meds overall, scoring 7.8/10 vs 7.3/10. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Shed for users who want fast delivery and a streamlined compounded gl.

A side-by-side comparison of Breeze Meds and Shed covering pricing, scores, medication types, insurance, and more to help you decide.

Breeze Meds

#34 of 48

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Higher Rated

Shed

#17 of 48

7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed

Feature	Breeze Meds	Shed
Our Score	7.3/10	7.8/10
Starting Price	$199/mo	$199/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Users who want a straightforward compounded GLP-1 program with fast shipping	Users who want fast delivery and a streamlined compounded GLP-1 experience
Ranking	#34	#17

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required — order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Very limited independent reviews and unclear company structure — legitimacy is hard to verify
−Oral options at $299-399/mo are significantly more expensive than injectable alternatives
−Not available in all 50 states — varies by provider licensure in your state

Shed

Pros

+Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
+$149/mo is competitively priced for an all-inclusive compounded program with good support
+Streamlined onboarding with no video call — approved and shipped faster than most competitors
+Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

−Compounded semaglutide and tirzepatide only — no brand-name options
−Newer company (founded 2024) with limited track record and outcome data
−No insurance billing and no FSA/HSA superbills currently available
−Clinical support is responsive but less proactive than premium platforms

Our Verdict

Shed edges out Breeze Meds with a score of 7.8/10 vs 7.3/10. Shed offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Breeze Meds nor Shed feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review